Can Myokardia Inc (NASDAQ:MYOK)’s Tomorrow be Different? The Stock Had Increase in Shorts

June 2, 2018 - By Clifton Ray

MyoKardia, Inc. (NASDAQ:MYOK) Logo

The stock of Myokardia Inc (NASDAQ:MYOK) registered an increase of 7.48% in short interest. MYOK’s total short interest was 2.38M shares in June as published by FINRA. Its up 7.48% from 2.21M shares, reported previously. With 172,900 shares average volume, it will take short sellers 14 days to cover their MYOK’s short positions. The short interest to Myokardia Inc’s float is 8.16%.

The stock increased 1.79% or $0.85 during the last trading session, reaching $48.45. About 292,328 shares traded. MyoKardia, Inc. (NASDAQ:MYOK) has risen 269.77% since June 2, 2017 and is uptrending. It has outperformed by 257.20% the S&P500.

MyoKardia, Inc., a clinical stage biopharmaceutical company, engages in discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. The company has market cap of $1.92 billion. The Company’s lead product candidate is MYK-461, an orally-administered small molecule that is in Phase II clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy . It currently has negative earnings. The firm also develops MYK-491, an orally-administered small molecule that treats genetic dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart.

More important recent MyoKardia, Inc. (NASDAQ:MYOK) news were published by: which released: “MyoKardia Announces Pricing of Public Offering of Common Stock” on May 23, 2018, also published article titled: “MyoKardia Announces Proposed Public Offering of Common Stock”, published: “MyoKardia Reports First Quarter 2018 Financial Results” on May 08, 2018. More interesting news about MyoKardia, Inc. (NASDAQ:MYOK) was released by: and their article: “Myokardia’s (MYOK) CEO Tassos Gianakakos on Q1 2018 Results – Earnings Call Transcript” with publication date: May 09, 2018.

MyoKardia, Inc. (NASDAQ:MYOK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.